← companies

Elevance Health (ELV)

point-in-time fundamentals

The latest fundamentals for Elevance Health that were publicly knowable as of 2026-02-06, straight from its SEC filings. Every value is stamped with the date it first became public — so a backtest of ELV can only see what was real at the time. No lookahead bias.

Latest knowable fundamentals

ConceptFYFirst-reported valueBecame public
RevenueFY2025$199.1B2026-02-06
Net incomeFY2025$5.7B2026-02-06
Operating cash flowFY2025$4.3B2026-02-06
Total assetsFY2025$121.5B2026-02-06
Stockholders' equityFY2025$43.9B2026-02-06
Diluted EPSFY2025$25.212026-02-06
Diluted sharesFY2025225M sh2026-02-06

Revenue, as first reported

What ELV's annual revenue was on the day each 10-K was filed — the honest number a backtest could have used.

Fiscal yearRevenue (first reported)Filed
FY2025$199.1B2026-02-06
FY2024$177.0B2025-02-20
FY2023$171.3B2024-02-21
FY2022$156.6B2023-02-15
FY2021$138.6B2022-02-16
FY2020$121.9B2021-02-18
get this via API
curl "https://tradevodata.com/v1/fundamentals?ticker=ELV&as_of=2023-06-30" \
  -H "x-api-key: tvd_your_key"

For any as_ofdate, the API returns each concept's latest value that was already public then — a point-in-time snapshot, not a multi-year array. Walk history by repeating the request with earlier as_of dates. This page shows only the latest snapshot.

Why does the filing date matter? Read: your backtest saw the future.

Backtest ELV — and 5,200+ others — without lookahead bias.

quarterly (10-q) waitlist

Annual data only, for now. Be first to know when quarterly ships.

Source: U.S. SEC EDGAR (public domain). Values are first-reported (point-in-time); not investment advice. Verify against primary filings before relying on them.